BASF launches omega 3 solution for the dietary management of NAFLD
date:Dec 04, 2019
unwanted lipids such as cholesterol, which are naturally found in all fish oil-based products. Research on rodents has also shown that one specific environmental pollutant, PCB 153, contributes to the development of NAFLD, BASF highlights. Hepacor is manufactured to minimize unnecessary exposure of NAFLD patients to such unwanted components of fish oil.

BASF was looking for a partner that has the required commercial competencies, local market knowledge, access and size to lift such an opportun
8/9 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/29 05:45